If successful, the vaccine could protect women against ovarian cancer, which only around half of women survive long-term at the moment.

The first ovarian cancer vaccine is being developed, and creators and hopeful it could wipe out the disease. The UK is currently developing the world’s first vaccine for ovarian cancer at the University of Oxford.

A laboratory hoping to develop a vaccine for ovarian cancer has been awarded funding. Scientists at the University of Oxford are creating OvarianVax, a vaccine which they hope will teach the immune system to recognise and attack the earliest stages of ovarian cancer.

The vaccines are still in early development, but if tests are successful, they could help prevent one of the most common forms of cancer for women.

The world’s first ovarian cancer vaccine has been awarded research funding in the United Kingdom, marking the first step toward a groundbreaking preventive measure that scientists say could eliminate the disease entirely.

A first-ever ovarian cancer vaccine – currently being developed by the University of Oxford hopes to wipe off the deadly cancer – which kills thousands of women across the world yearly. According to scientists – the jab could be given to all women preventatively to eliminate the disease,